Incidence of hepatocellular carcinoma in chronic hepatitis C patients who were treated with direct acting antiviral agents: A nationwide multicenter prospective cohort study

被引：0
|
作者：
Jang, Eun Sun [1 ]
Kim, Young Seok [2 ]
Kim, In Hee [3 ]
Lee, Youn Jae [4 ]
Cho, Sung Beom [5 ]
Jeong, Sook-Hyang [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Internal Med GI Hepatol, Bundanggu, South Korea
[2] Soon Chun Hyang Univ, Bucheon Hosp, Dept Internal Med, Bucheon, South Korea
[3] Chungbuk Natl Univ Hosp, Dept Internal Med, Chonju, South Korea
[4] Inje Univ, Busan Paik Hosp, Dept Internal Med, Busan, South Korea
[5] Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Chungnam, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
hepatitis C virus; direct acting antiviral agents; hepatocellular carcinoma; prospective; cohort;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
EE-0351 (P
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [1] Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study
    Ide, Tatsuya
    Koga, Hironori
    Nakano, Masahito
    Hashimoto, Satoru
    Yatsuhashi, Hiroshi
    Higuchi, Nobito
    Nakamuta, Makoto
    Oeda, Satoshi
    Eguchi, Yuichiro
    Shakado, Satoshi
    Sakisaka, Shotaro
    Yoshimaru, Yoko
    Sasaki, Yutaka
    Honma, Yuichi
    Harada, Masaru
    Seike, Masataka
    Maeshiro, Tatsuji
    Miuma, Satoshi
    Nakao, Kazuhiko
    Mawatari, Seiichi
    Ido, Akio
    Nagata, Kenji
    Matsumoto, Shuichi
    Takami, Yuko
    Sohda, Tetsuo
    Kakuma, Tatsuyuki
    Torimura, Takuji
    HEPATOLOGY INTERNATIONAL, 2019, 13 (03) : 293 - 301
  • [2] Hepatitis C Virus - Related Hepatocellular Carcinoma in the Era of Direct - Acting Antiviral Agents
    Liu, Xu
    Gao, Yanhang
    Niu, Junqi
    HEPATITIS MONTHLY, 2018, 18 (06)
  • [3] Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study
    Tatsuya Ide
    Hironori Koga
    Masahito Nakano
    Satoru Hashimoto
    Hiroshi Yatsuhashi
    Nobito Higuchi
    Makoto Nakamuta
    Satoshi Oeda
    Yuichiro Eguchi
    Satoshi Shakado
    Shotaro Sakisaka
    Yoko Yoshimaru
    Yutaka Sasaki
    Yuichi Honma
    Masaru Harada
    Masataka Seike
    Tatsuji Maeshiro
    Satoshi Miuma
    Kazuhiko Nakao
    Seiichi Mawatari
    Akio Ido
    Kenji Nagata
    Shuichi Matsumoto
    Yuko Takami
    Tetsuo Sohda
    Tatsuyuki Kakuma
    Takuji Torimura
    Hepatology International, 2019, 13 : 293 - 301
  • [4] Predictive Factors for Hepatocellular Carcinoma Occurrence or Recurrence after Direct-Acting Antiviral Agents in Patients with Chronic Hepatitis C
    Yoshimasu, Yu
    Furuichi, Yoshihiro
    Kasai, Yoshitaka
    Takeuchi, Hirohito
    Sugimoto, Katsutoshi
    Nakamura, Ikuo
    Itoi, Takao
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (01) : 63 - 71
  • [5] VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response
    Matono, Tomomitsu
    Tada, Toshifumi
    Nishimura, Takashi
    Takashima, Tomoyuki
    Aizawa, Nobuhiro
    Ikeda, Naoto
    Shiomi, Hideyuki
    Enomoto, Hirayuki
    Iijima, Hiroko
    JOURNAL OF MEDICAL ULTRASONICS, 2024, 51 (02) : 293 - 300
  • [6] Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents
    Hamoir, C.
    Horsmans, Y.
    Starkel, P.
    Dahlqvist, G.
    Dastis, S. Negrin
    Lanthier, N.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2021, 84 (01) : 25 - 32
  • [7] De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents
    Kuftinec, Gabriela
    Loehfelm, Thomas
    Corwin, Michael
    Durbin-Johnson, Blythe
    Candido, MarieChristi
    Hluhanich, Rebecca
    Sarkar, Souvik
    HEPATIC ONCOLOGY, 2018, 5 (01)
  • [8] Effectiveness of direct acting antiviral agents for hepatitis C virus related recurrent hepatocellular carcinoma patients who had multiple courses of recurrence
    Ohki, Takamasa
    Sato, Koki
    Kondo, Mayuko
    Goto, Eriko
    Sato, Takahisa
    Kondo, Yuji
    Akamatsu, Masatoshi
    Sato, Shinpei
    Yoshida, Hideo
    Koike, Yukihiro
    Obi, Shuntaro
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (11) : 1597 - 1603
  • [9] Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus plus Patients Treated with Direct-Acting Antiviral Agents
    Zou, Winnie Y.
    Choi, Kati
    Kramer, Jennifer R.
    Yu, Xian
    Cao, Yumei
    El-Serag, Hashem B.
    Kanwal, Fasiha
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (11) : 3328 - 3336
  • [10] Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents
    Winnie Y. Zou
    Kati Choi
    Jennifer R. Kramer
    Xian Yu
    Yumei Cao
    Hashem B. El-Serag
    Fasiha Kanwal
    Digestive Diseases and Sciences, 2019, 64 : 3328 - 3336
12345